CTVA · Categories · Offerings
CTVA - Public offerings
Corteva Inc. (CTVA) public offerings - real-time wire coverage filtered to Offerings only.
Recent Offerings for CTVA
- Corteva Announces Pricing of Senior Notes OfferingINDIANAPOLIS, May 12, 2025 /PRNewswire/ -- Corteva, Inc. ("Corteva") (NYSE:CTVA) today announced the pricing of a public offering by its direct subsidiary, EIDP, Inc. ("EIDP") of $500 million principal amount of its 5.125% Senior Notes due in 2032 (the "Notes"). The Notes will pay interest semi-annually at a rate of 5.125% per year and will mature on May 15, 2032. The net proceeds from the sale of the Notes will be used for general corporate purposes, including the redemption or repayment of the $500 million outstanding aggregate principal amount of EIDP's 1.700% Senior Notes due 2025 (the "2025 Notes"). This press release does not constitute a notice of redemption of the 2025 Notes.
- Corteva Announces Pricing of Senior Notes OfferingINDIANAPOLIS, May 11, 2023 /PRNewswire/ -- Corteva, Inc. ("Corteva") (NYSE:CTVA) today announced the pricing of a public offering by its direct subsidiary, EIDP, Inc. ("EIDP") totaling $1.2 billion of Senior Notes. The net proceeds from the sale of the Notes will be used for general corporate purposes. The public offering consists of $600 million aggregate principal amount of its 4.500% Senior Notes due in 2026 (the "2026 Notes"), which will be issued at 99.872% of their principal amount, and $600 million aggregate principal amount of its 4.800% Senior Notes due in 2033 (toget
- Evogene Reports Fourth Quarter and Full Year 2020 Financial ResultsREHOVOT, Israel, March 3, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product discovery and development across several market segments, announces today its financial results for the fourth quarter and full year ended December 31, 2020. Mr. Ofer Haviv, Evogene's President and CEO, stated, "2020 was a year of significant accomplishment for Evogene as we successfully realigned our organizational structure and core capabilities to dramatically accelerate the company's progress and value creation. Our excitement at Evogene today is primarily due to two substantial value creators that have resulte